NEOS Investment Management LLC Has $5.64 Million Stake in Healthpeak Properties, Inc. $DOC

NEOS Investment Management LLC raised its position in Healthpeak Properties, Inc. (NYSE:DOC) by 13.0% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 263,738 shares of the real estate investment trust’s stock after buying an additional 30,381 shares during the period. NEOS Investment Management LLC’s holdings in Healthpeak Properties were worth $5,644,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DOC. Bank of America Corp DE bought a new stake in shares of Healthpeak Properties in the 2nd quarter valued at about $234,600,000. Norges Bank acquired a new stake in Healthpeak Properties during the 4th quarter worth $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after acquiring an additional 7,007,777 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Healthpeak Properties by 20,832.8% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,217,474 shares of the real estate investment trust’s stock worth $133,054,000 after acquiring an additional 6,187,772 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Healthpeak Properties by 60.3% during the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust’s stock worth $253,949,000 after purchasing an additional 5,815,189 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $20.65 on Monday. The stock’s 50-day simple moving average is $21.55 and its 200 day simple moving average is $19.35. The firm has a market capitalization of $14.24 billion, a PE ratio of 59.00, a price-to-earnings-growth ratio of 2.55 and a beta of 1.01. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.95.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. The business had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.Healthpeak Properties’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, analysts anticipate that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 5.9%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s payout ratio is presently 348.57%.

Analyst Ratings Changes

DOC has been the subject of a number of research reports. Robert W. Baird increased their target price on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Thursday, August 13th. Wells Fargo & Company upped their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 15th. Cantor Fitzgerald boosted their price target on Healthpeak Properties from $20.00 to $23.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Scotiabank increased their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a report on Wednesday, May 27th. Finally, Evercore lowered shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a research note on Monday, May 11th. Four equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $21.72.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.